Changeflow GovPing Healthcare & Life Sciences QIPB in Hip Surgery - Opioid Consumption Measur...
Routine Notice Added Final

QIPB in Hip Surgery - Opioid Consumption Measurement Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

This single-center retrospective study registered on ClinicalTrials.gov examines patients who underwent hip surgery between May 2025 and November 2025. The study compares patients receiving Quadro Iliac Plane Block (QIPB) plus patient-controlled analgesia against a control group using only patient-controlled analgesia. Primary endpoint is total opioid consumption over 24 hours, with secondary endpoints including pain scores and rescue analgesia requirements.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document registers a new clinical study on ClinicalTrials.gov evaluating Quadro Iliac Plane Block (QIPB) for postoperative pain management in hip surgery patients. The study screens ASA physical status I-III patients aged 18 and older, comparing opioid consumption between a block group and a control group over a 24-hour postoperative period.

Healthcare providers and clinical investigators conducting or reviewing perioperative pain management protocols may find this registry entry relevant for evidence synthesis on regional anesthesia techniques for hip surgery. The study's focus on tramadol consumption and rescue analgesia requirements adds to the body of literature on opioid-sparing analgesia approaches.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

QIPB in Hip Surgery

N/A NCT07540676 Kind: NA Apr 20, 2026

Abstract

In this single-center retrospective study, patients who underwent hip surgery between May 2025 and November 2025, with American Society of Anesthesiology (ASA) physical status I-III, aged 18 years and older, were screened. Patients who did not undergo a block for postoperative analgesia and who used patient-controlled analgesia were included in the control group. Patients who underwent QIPB and used patient-controlled analgesia were included in the block group. Patients' postoperative tramadol consumption, pain scores assessed using the Numerical Rating Scale, and rescue analgesia requirements were recorded. The primary endpoint was total opioid consumption over 24 hours, and the secondary endpoints were postoperative pain scores and rescue analgesia requirements.

Conditions: Hip Surgeries

Interventions: Quadro iliac Plane Block

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07540676

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Postoperative pain management Opioid consumption research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!